Sana Biotechnology Income Statement (2020-2026) | SANA

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter)
45.00M53.24M108.50M72.69M72.54M76.73M63.92M67.17M73.04M65.61M7.00M56.45M60.87M53.21M1.90M37.19M29.76M30.11M34.92M28.72M
Selling, General & Administrative (Quarter)
12.48M13.43M12.68M14.43M18.29M15.51M23.32M16.77M16.57M19.18M20.78M16.27M16.44M14.05M17.28M11.48M10.34M10.29M12.19M11.46M
Other Operating Expenses (Quarter)
16.75M-9.90M-55.44M-17.93M-6.06M-249.44M0.12M26.68M-82.61M62.84M-68.66M-72.02M-5.50M-16.57M1.96M-37.86M3.12M196.68M8.43M
Operating Expenses (Quarter)
57.47M83.43M111.28M31.68M72.90M86.19M-162.20M84.05M116.29M2.18M90.62M4.06M5.29M61.76M2.60M50.63M2.24M43.52M243.79M48.61M
Operating Income (Quarter)
18.55M-83.43M-111.28M-31.68M-72.90M-86.19M-81.79M-84.05M-116.29M-2.18M-90.62M-110.72M-49.37M-61.76M-50.87M-50.63M-94.97M-43.52M-61.20M-48.61M
EBIT (Quarter)
18.55M-83.43M-111.28M-31.68M-72.90M-86.19M-81.79M-84.05M-116.29M-2.18M-90.62M-110.72M-49.37M-61.76M-50.87M-50.63M-94.97M-43.52M-61.20M-48.61M
Non-operating items
Interest & Investment Income (Quarter)
0.13M0.16M0.27M0.34M0.64M1.17M1.61M1.98M2.37M2.86M2.73M3.03M3.20M2.58M1.66M0.99M0.58M1.00M1.28M0.95M
Other Non Operating Income (Quarter)
0.00M0.01M0.28M-0.10M-0.20M-0.11M-0.27M-0.05M-0.08M0.30M-0.22M0.21M-4.12M-0.74M0.14M0.25M0.60M0.36M1.10M0.45M
Non Operating Income (Quarter)
0.00M0.01M0.28M-0.10M-0.20M-0.11M-0.27M-0.05M-0.08M0.30M-0.22M0.21M-4.12M-0.74M0.14M0.25M0.60M0.36M1.10M0.45M
Net income details
EBT (Quarter)
18.68M-83.27M-111.01M-31.35M-72.27M-85.01M-80.17M-82.08M-113.92M0.68M-87.89M-107.69M-46.17M-59.18M-49.21M-49.64M-94.40M-42.51M-59.92M-47.66M
Profit After Tax (Quarter)
18.68M-83.26M-110.73M-31.45M-72.47M-85.12M-80.44M-82.12M-114.00M0.98M-88.12M-107.47M-50.29M-59.92M-49.07M-49.39M-93.80M-42.15M-58.83M-47.21M
Income from Continuing Operations (Quarter)
18.68M-83.27M-111.01M-31.35M-72.27M-85.01M-80.17M-82.08M-113.92M0.68M-87.89M-107.69M-46.17M-59.18M-49.21M-49.64M-94.40M-42.51M-59.92M-47.66M
Consolidated Net Income (Quarter)
18.68M-83.27M-111.01M-31.35M-72.27M-85.01M-80.17M-82.08M-113.92M0.68M-87.89M-107.69M-46.17M-59.18M-49.21M-49.64M-94.40M-42.51M-59.92M-47.66M
Income towards Parent Company (Quarter)
18.68M-83.27M-111.01M-31.35M-72.27M-85.01M-80.17M-82.08M-113.92M0.68M-87.89M-107.69M-46.17M-59.18M-49.21M-49.64M-94.40M-42.51M-59.92M-47.66M
Net Income towards Common Stockholders (Quarter)
18.68M-83.27M-111.01M-31.35M-72.27M-85.12M-80.17M-82.08M-113.92M0.98M-87.89M-107.69M-46.17M-59.92M-49.21M-49.64M-94.40M-42.51M-59.92M-47.66M
Additional items
EPS (Basic) (Quarter)
0.10-0.46-0.61-0.17-0.39-0.45-0.42-0.43-0.590.00-0.45-0.49-0.21-0.25-0.21-0.21-0.39-0.16-0.21-0.17
EPS (Weighted Average and Diluted) (Quarter)
0.09-0.46-0.61-0.17-0.39-0.45-0.42-0.43-0.59-0.45-0.49-0.21-0.25-0.21-0.21-0.39-0.16-0.21-0.17
Shares Outstanding (Weighted Average) (Quarter)
149.68M160.51M166.43M185.96M186.80M189.30M188.34M191.23M191.89M196.98M194.54M217.29M225.87M229.08M230.89M237.58M238.00M245.58M253.23M276.86M
Shares Outstanding (Diluted Average) (Quarter)
181.83M166.43M185.96M186.80M189.30M188.34M191.23M191.89M194.54M217.29M234.44M229.08M230.89M237.58M238.00M245.58M253.23M276.86M
EBITDA (Quarter)
18.64M-83.36M-112.02M-35.25M-73.64M-85.19M-78.36M-79.94M-112.72M1.65M-87.97M-107.43M-50.30M-59.85M-49.11M-49.40M-93.80M-42.13M-58.82M-47.24M
Shares Outstanding (Quarter)
180.58M182.91M184.93M186.63M188.43M189.88M191.02M191.41M196.88M197.06M197.86M221.29M222.21M223.11M223.92M225.46M230.51M262.26M266.73M269.82M